Pfizer's strategic weaknesses mount and the stock became overvalued after the recent rally. Read more to see our analysis on ...

Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, ...

NEW YORK, May 06, 2024--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the ...

The pharmaceutical giant's quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral ...

By Colin Kellaher Pfizer had hired Andrew Baum as the drugmaker's next chief strategy and innovation officer. Pfizer on Monday said Baum, who has been ...

Biopharma giant Pfizer Inc. (NYSE: PFE) has given back all its COVID gains and more. Shareholders have sat through a painful ...

Pfizer, a leading American pharmaceutical company, is redirecting its attention towards the cancer treatment market following ...

Pfizer stock rose as markets opened Wednesday following an earnings report that included sales growth among Pfizer's ...

Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and ...

Physicians are unequivocal about who is the big kahuna in the vaccine industry. | Physicians are unequivocal about who is the ...

Where there's a will, there's a way. And Pfizer appears to have the will to stake a claim in the massive obesity drug market.

Pfizer’s stock price rose 6% by the end of the day Wednesday to $27.18.